LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 6,762 | $26,439 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 263,349 | $1,029,695 | 0.00% |
| Citadel Advisors | 6,000 | $23,460 | 0.00% |
| Citadel Advisors | 1,500 | $5,865 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 162,860 | $636,783 | 0.00% |
| SIMPLEX TRADING, LLC | 84 | $0 | 0.00% |
| Qube Research & Technologies Ltd | 3,282 | $12,833 | 0.00% |
| SIGNATUREFD, LLC | 500 | $1,955 | 0.00% |
| JPMORGAN CHASE & CO | 34 | $133 | 0.00% |
| Renaissance Technologies | 49,800 | $195 | 0.00% |
| ROYAL BANK OF CANADA | 3,271 | $13,000 | 0.00% |
| VANGUARD GROUP INC | 864,332 | $3,379,538 | 0.00% |
| UBS Group AG | 18 | $70 | 0.00% |
| RHUMBLINE ADVISERS | 296 | $1,156 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 16,420 | $64,202 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,500 | $5,865 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 28,254 | $110,473 | 0.00% |
| US BANCORP \DE\ | 500 | $1,955 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 125,954 | $492,480 | 0.00% |
| WELLS FARGO & COMPANY/MN | 221 | $864 | 0.00% |
External links
This page lists LYRA THERAPEUTICS INC's shareholders in Q3 2023. To view LYRA THERAPEUTICS INC's shareholder history, click here.